Cellectis (ADR)
Develops gene-edited allogeneic CAR-T candidates and manufacturing capabilities.
$3.41
After-hours close−0.02 (−0.58%)
At close$3.43(−2.28%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 10.22%Insiders —
Shares outstanding 100.42M · Float 85.65M · 85.3% free float
Institutions13F, as of Mar 31, 2026
33 holders · 10.26M shares · 5 new positions · 8 increased · 14 reduced · 6 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| B Group, Inc. | 3.28M | 3.27% | 0 | May 15, 2026 |
| UBS Asset Management Americas Inc | 3.18M | 3.17% | 0 | May 13, 2026 |
| Long Focus Capital Management, LLC | 2.74M | 2.73% | −43.7K | May 15, 2026 |
| BlackRock, Inc. | 341.5K | 0.34% | −42.8K | May 13, 2026 |
| Macquarie Management Holdings, Inc. | 226.9K | 0.23% | 0 | May 15, 2026 |
| Morgan Stanley | 86.8K | 0.09% | −400 | May 15, 2026 |
| LPL Financial LLC | 84.3K | 0.08% | −447 | May 6, 2026 |
| Susquehanna International Group, LLP | 65.9K | 0.07% | +13.5K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| AstraZeneca Holdings B.V.incl. AstraZeneca PLC | 44.00% | 44.00M | 13D | Jan 24, 2025 ↗ |
| Caisse des Depotsincl. Bpifrance Participations S.A., Bpifrance S.A. +2 more | 11.10% | 10.60M | 13D | Dec 12, 2025 ↗ |
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.